CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia

NCT06696846 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory T-cell Lymphoma
Relapsed/Refractory Acute Myeloid Leukemia

Interventions

BIOLOGICAL: CD70 CAR-NK

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University